ストックスクリーナーアプリを入手
6.045
0.58%
0.035
前日終値:
$6.01
開ける：
$6.1
24時間の取引高:
37,558
Relative Volume:
0.08
時価総額：
$76.93M
収益：
$134.00K
当期純損益:
$-33.51M
株価収益率:
-1.8847
EPS:
-3.2074
ネットキャッシュフロー:
$-18.15M
1週間 パフォーマンス:
-1.79%
1か月 パフォーマンス:
+10.92%
6か月 パフォーマンス:
-3.74%
1年 パフォーマンス:
+56.20%
1日の値動き範囲:
$5.83
$6.10
1週間の範囲:
$5.83
$6.4219
52週間の値動き範囲:
$3.25
$13.50
Clene Inc Stock (CLNN) Company Profile
名前
Clene Inc
セクター
電話
801-676-9695
住所
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
6.02 | 77.95M | 134.00K | -33.51M | -18.15M | -3.2074 |
VRTX
Vertex Pharmaceuticals Inc
|
524.26 | 134.02B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
673.41 | 68.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
924.88 | 58.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.97 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
192.34 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-10-04 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-07-18 | 開始されました | H.C. Wainwright | Buy |
| 2022-05-02 | 開始されました | Canaccord Genuity | Buy |
| 2021-09-28 | 開始されました | Oppenheimer | Outperform |
Clene Inc (CLNN) 最新ニュース
Clene Company Profile & Introduction - Moomoo
Clene Inc.(NasdaqCM: CLNN) added to Russell Microcap Value Benchmark Index - marketscreener.com
Clene Inc.(NasdaqCM: CLNN) added to Russell Microcap Index - marketscreener.com
CLNN Stock Rises 8% – Here’s What The FDA Update Means For Clene’s ALS Treatment - Stocktwits
Clene Inc.(NasdaqCM: CLNN) added to Russell 3000E Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Clene Inc. – NASDAQ:CLNN - TradingView
Price to earnings forward of Clene Inc. – NASDAQ:CLNN - TradingView
Price to earnings forward of Clene Inc. – BOATS:CLNN - TradingView
Clene Inc Actuals & Estimates (NASDAQ:CLNN) - TradingView
Enterprise value to EBITDA forward of Clene Inc. – BOATS:CLNN - TradingView
Enterprise value to EBIT forward of Clene Inc. – BOATS:CLNN - TradingView
Enterprise value to revenue forward of Clene Inc. – BOATS:CLNN - TradingView
CLNN Forecast — Price Target — Prediction for 2027 - TradingView
Clene Inc. (CLNN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clene Inc. (CLNN) Holds Near Support as Consolidation Persists Amid Minor DeclineLiquidity Order Flow - dars.gov.et
CLNN Q1 2026 Earnings: Clinical-Stage Biotech Delivers Narrower-Than-Expected Loss Despite No RevenueROA Comparison - dars.gov.et
Clene Inc. (CLNN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clene Inc. (CLNNW) Institutional Confidence - TradingKey
Clene Inc. (CLNNW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clene Inc. (CLNNW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clene Inc. (CLNNW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Clene Inc. (CLNNW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Clene Inc. (CLNNW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clene Inc. (CLNN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? - Yahoo Finance
Clene Inc. (CLNN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clene Inc. (CLNNW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Clene Inc. (CLNN) Institutional Confidence - TradingKey
Clene Inc. (CLNN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Clene Inc. (CLNNW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clene Inc. (CLNNW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clene Inc. (CLNN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clene Inc. (CLNN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Clene Inc. (CLNN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clene (CLNN) Chief Science Officer receives 45,000-share stock option grant - Stock Titan
Clene (CLNN) CEO receives 65,000 stock options at $5.53 exercise price - Stock Titan
Clene (CLNN) grants CFO 15,000 stock options at $5.53 strike - Stock Titan
Clene Inc. (CLNN) Gains 5.6% as Shares Approach Key ResistanceOversold Bounce Ideas - newsline.com
Clene stock jumps after FDA opens door to accelerated approval for ALS drug - MSN
TruckMountForums acquires Bane-Clene Corporation, uniting two fam - The National Law Review
TruckMountForums acquires Bane-Clene Corporation, uniting two family-owned pillars of the professional - EIN News
Clene (CLNN) may find a bottom soon, here's why you should buy the stock now - MSN
CLNN Q1 2026 Earnings: EPS Beats Expectations Amid No Revenue, Stock DeclinesOne-Time Loss Impact - newsline.com
Clene (CLNN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
CLNN Q1 2026 Earnings: EPS Surprises to the Upside as Company Focuses on Clinical MilestonesBasic EPS Analysis - dars.gov.et
CLNN Q1 2026 Earnings: Significant EPS Beat But Stock SlidesSpecial Dividend Alert - newsline.com
CLNNClene Inc Stock Price and Quote - Finviz
CLNN Technical Analysis & Stock Price Forecast - Intellectia AI
Clene Inc. (CLNN) Shares Slide 2.24% as Stock Tests Key Support LevelsThrowback Trade - thelegaladvocate.com
CLNN Q1 2026 Earnings: EPS Beat Driven by Cost Control Amid No RevenueTangible Book Value - newsline.com
CLNN stock falls after Roth labels accelerated approval for ALS drug a 'long shot' - MSN
Clene Inc (CLNN) 財務データ
収益
当期純利益
現金流量
EPS
Clene Inc (CLNN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Ugwumba Chidozie | 10% Owner |
May 11 '26 |
Sale |
6.75 |
22,177 |
149,695 |
176,713 |
1.83%
3.59%
大文字化:
|
ボリューム (24 時間):